Qing Hao and malaria, cancer studies

[Guest guest]

http://www.cancer-coverup.com/newsletter/06-2004/default.asp?

linkref=nl_0604

 

AN HERBAL MIRACLE DRUG?

TRADITIONAL CHINESE HERB OFFERS CURE FOR MALARIA AND POSSIBLY CANCER

 

 

BY KATHLEEN B. DEOUL

 

What if there was a disease that killed between 1.5 and 2.7 million

people a year, including at least one million children that could be

easily treated with a simple herbal extract that had negligible side

affects? What if had been known for decades that this cheap, well-

tolerated

cure was available, but its use was blocked by institutions such as

the

World Health Organization and UNICEF - the very ones charged with

improving global health? What if this disease were beginning to

spread from

the underdeveloped world to Europe and the United States?

 

Would someone be held accountable for the needless deaths and growing

threat?

 

Apparently not, because that is exactly what has happened with

Malaria

- but that's only half of the story.

 

THE SCOURGE OF MALARIA

 

Malaria is one of the triumvirate of diseases that has devastated the

developing world. Along with AIDS and Tuberculosis, it has reached

pandemic proportions in Asia and Africa with some 120 million

clinical cases

reported annually. Although the vast majority of Malaria deaths occur

in Africa, at lease 40% of the World's population has been exposed to

the parasite. Indeed, it is estimated that 300 million people carry

the

parasite. This compares with around 40 million AIDS carriers and is

exceeded only by Tuberculosis which may be carried by as much as one-

third

of the world's population.

 

What is particularly disturbing about Malaria, however, is that over

the last century every time a new drug has been developed to combat

it,

the parasite has adapted and developed a resistance. In the 1950s

quinine-based drugs such as Chloraquine and Primaquine proved highly

effective in combating Malaria, but today, anywhere from 50% to 90%

of new

cases are proving resistant.

 

Over the past fifteen years, the older quinine-based drugs were

replaced as the treatment of choice by Lariam (Mefloquine), a drug

developed

by the United States Army for soldiers serving in Vietnam. Lariam was

first produced at the Walter Reed Army Institute of Research in 1963.

Licensed to Swiss pharmaceutical giant Hoffman LaRoche, it was

approved

for general use in May of 1989. Each year, thousands of civilians

traveling abroad as well as U.S. military and Peace Corps personnel

take

Lariam to protect them against Malaria.

 

PROBLEMS WITH LARIAM

 

However, like their predecessors, drugs such as Lariam are now also

losing their effectiveness. Moreover, serious side effects have been

associated with Lariam, including extreme neuropsychiatric disorders.

These

disorders are suspected of sparking a series of murders at Ft. Bragg,

N.C. by soldiers returning from Afghanistan where they were

administered

the drug.

 

Concern over the possible neuropsychiatric side effects of Lariam

caused the FDA to require a change to the product's label in 2002

that reads

in part:

 

" Mefloquine may cause psychiatric symptoms in a number of patients

ranging from anxiety, paranoia and depression to hallucinations and

psychotic behavior. On occasions these symptoms have been reported to

continue

long after mefloquine has been stopped. Rare cases of suicidal

ideation

and suicide have been reported though no relationship to drug

administration has been confirmed. "

 

What makes the concern over growing drug resistance to Malaria an

even

more urgent problem is that the increase in global travel, especially

to areas such as Africa and Southeast and Southwest Asia where

Malaria

is common raise the specter of its return to the United States. Other

tropical diseases such as the West Nile Virus have already made there

way

here, and some fear it is only a matter of time before Malaria does

so

as well.

 

But is there a solution?

 

AN HERBAL SOLUTION?

 

Surprisingly, one has been available for at least three decades, but

it

has been resisted by both Big Pharma and the international

institutions

that do its bidding.

 

At about the same time the U.S. Army was looking for a new Malaria

drug

to give to soldiers fighting in Vietnam, the Chinese military was

engaged in the same task to protect their own troops and those of

North

Vietnam. Their approach, however, was quite different.

 

China has a tradition of using herbal medicine that dates back over

2,000 years. In 1965, Chinese military researchers began looking at

traditional herbal remedies to see if they could find one that was

effective

against the strain of Malaria endemic to Vietnam. In short order they

hit on an herb known as " sweet wormwood. "

 

Sweet wormwood had been used to treat a variety of illnesses in China

for more than two millennia. Normally administered as a tea, it had

no

noticeable side effects and seemed quite effective. The Chinese

military

researchers were able to isolate the active ingredient in sweet

wormwood, a substance called Artemisinin, and to develop a simple

process to

extract it.

 

The results were astounding.

 

ARTEMISININ'S EFFECTIVENESS

 

They found that Artemisinin was effective against all strains of

Malaria, and more important, its therapeutic action was stunningly

rapid. In

one clinical trial, it was found to destroy 95% of the Malaria

parasites in patients within twenty hours. The fever typically

accompanying a

Malaria infection was gone within eight hours. Moreover, there were

no

side effects. Other studies of Artemisinin confirmed its

effectiveness

and rapid action - something particularly important for the treatment

of

very young children who account for 90% of all Malaria deaths.

 

But that wasn't all of the good news concerning Artemisinin.

 

Because sweet wormwood is easy to cultivate and because the

extraction

process to separate out the Artemisinin is simple, it was cheap to

manufacture. In other words, it was the perfect answer to the

developing

world's Malaria pandemic.

 

Of course, this new " miracle " cure was embraced by the World Health

Organization, UNICEF and the other international organizations trying

to

combat global public health problems - at least that's what you would

think. Unfortunately you would be wrong.

 

Their reaction was exactly the opposite.

 

ESTABLISHMENT RESISTANCE AND REVERSAL

 

In 2002, Dr. Dennis Carroll, a health advisor to the Agency for

International Development called Artemisinin " … not ready for prime

time … "

 

The World Bank and UNICEF objected to the herbal remedy claiming it

was

" too expensive. " At the time, a dose of Artemisinin sold for around

$2

whereas a single dose of Lariam costs from $4.50 to $6.00!

 

Suddenly, last April, Dr. Carroll reversed himself and became a

cheerleader for Artemisinin.

 

How could this happen?

 

Well, he was not exactly a cheerleader for Artemisinin. Rather, he

became a cheerleader for what is termed " ACT " or " Artemisinin

Combination

Therapy. " Under this approach Artemisinin is combined with a

pharmaceutical product - usually a drug called Lumefantrine that is

produced by

Novartis, the huge Swiss drug conglomerate. Interestingly, in poor

countries Novartis sells the combination under the brand

name " Coartem " for

about 90 cents a dose. In the Developed World, however, it sells the

same drug under the brand name Riamet for around $20 a dose.

 

While Novartis could not patent Artemisinin, because as a plant, it

was

a naturally occurring substance, it can patent the combination -

ensuring its coffers will be fattened!

 

But that's not all!

 

Even though the World Health Organization now says it needs at least

100 million doses of the combination drug by next year, Novartis

managed

to get it qualified as an " orphan drug " under FDA regulations making

it

eligible for preferential tax and investment treatment!

 

So now that Big Phama can make a profit, the ancient Chinese herb has

suddenly become the " next new thing " in the pharmaceutical industry.

 

The question is how many children died needlessly while greedy

executives in corporate board rooms were protecting their profits?

 

If you only take the period from 1989 when Lariam, the last " next new

thing " for Malaria came onto the market into account, the death toll

comes to around 15 million!

 

But at least Artemisinin is now becoming available, and not a moment

too soon, because conventional pharmaceutical remedies are rapidly

losing

their effectiveness.

 

In Uganda, for example, a country which had not previously had a

significant drug resistance problem, the number of Malaria cases not

responding to existing pharmaceutical products rose from 6% in 2000

to 31% in

2003. Similar patterns of rapidly growing drug resistance are being

experienced elsewhere.

 

BIG PHARMA'S PLOY

 

Of course, Big Pharma uses this fact as a justification for using a

" combined drug therapy. " They claim that using Artemisinin in

combination

with Lumefantrine will protect the herb against losing its

effectiveness. This makes sense on first glance except for one thing:

Artemisinin

has been used for over 2,000 years without losing its punch.

 

Why would it suddenly do so now?

 

The simple truth is that Novartis is not afraid of Artemisinin losing

its medicinal power. It's afraid of losing the drug's financial

power.

As long as it is sold in combination with a conventional

pharmaceutical

product, the combination can be patented even if the herb cannot.

That

means that whenever the patent on Lumefantrine is set to expire, all

that Novartis has to do is combine it with another pharmaceutical

product

- it really doesn't matter what since it's the herb that's providing

the greatest medical benefit - and apply for a new patent! It

effectively

creates Big Pharma's fondest dream - a patent that will never expire!

 

Not only that, but by following the two-tiered sales approach and

having one relatively cheap brand name Novartis uses in poor

countries and

another expensive one for the rest of the world, the company can

continue to watch its profits grow while avoiding criticism for

exploiting

poor nations.

 

As if its indefinite patent protection weren't enough, institutions

such as the World Health Organization, the Global Fund for AIDS

Tuberculosis and Malaria and the U.S. Agency for International

Development are

providing grants to farmers to grow more sweet wormwood so that

sufficient supplies of the herb are available. That these grants also

serve to

keep manufacturing costs down for Novartis thereby making their

profits

larger is yet another benefit to the pharmaceutical giant.

 

But how does Artemisinin work? The answer to this question may have

implications for global health that go far beyond its effectiveness

against Malaria.

 

Artemisinin contains a bioactive peroxide molecule. It is this

molecule

that is the key to its effectiveness against the Malaria parasite.

Malaria grows in the body's erythrocytes, or red blood cells.

Hemoglobin, a

major component of red blood cells, contains large amounts

of " unbound "

or free iron. The iron plays a crucial role in the function of red

blood cells to transport oxygen throughout the body. The peroxide

molecule

in Artemisinin reacts with the iron in the red blood cells to create

free radicals that in turn destroy the parasite's membranes, killing

it.

This mechanism may be the reason why Malaria parasites are unable to

develop a resistance to Artemisinin.

 

The belief that oxygen plays a key role in the Artemisinin anti-

malaria

mechanism has been reinforced by studies of derivatives of the

substance that do not contain the peroxide molecule. These were found

to be

ineffective against malaria. Further, when other drugs such as

miconazole

and doxorubicin that also generate free radicals through an oxygen

interaction were used in conjunction with Artemisinin, its effect was

enhanced. Conversely when substances that retard free radical

creation such

as vitamin E were used in conjunction, its effect was reduced.

 

In a separate study where the antioxidant defenses of rats were

manipulated, it was discovered that those with weaker antioxidant

defenses

were more resistant to the Malaria parasite, whereas those with

enhanced

antioxidant defenses were more vulnerable to the disease.

 

But why is it so important that Artemisinin transport oxygen to

cells?

The answer lies in the research of German Nobel Laureate Otto

Warburg.

 

A POSSIBLE CANCER CURE?

 

Warburg won the Nobel Prize in 1928 for describing the way a cancer

cell functions. A key element of his research was to establish that

cancer

cells were " anaerobic. " That is to say that they required an ABSENCE

of

oxygen to survive. Since 1928, countless researchers have worked to

find a way to transport oxygen to cancer cells. Although some

researchers,

such as Dr. Keith Brewer, developed treatments based on this

principle,

their discoveries were either ignored or attacked.

 

But in the case of Artemisinin, the fact that it is approved by the

FDA

for use in humans may finally open the door to an oxygen-based

approach

to cancer treatment. Once a drug is approved for one purpose, it can

be

prescribed by physicians to treat any disease they deem appropriate.

This practice is called " off-label prescribing " and is widespread

within

the medical community. Soon, though, it may not be necessary to

engage

in such subterfuge.

 

Professor Henry Lai and Assistant Professor Narendra Singh of the

University of Washington have been conducting in vitro experiments to

determine the effectiveness of Artemisinin in fighting cancer. A

study

concerning their research published in the Journal Life Sciences

described

how the compound killed virtually all human breast cancer cells

exposed

to it within sixteen hours.

 

According to Dr. Lai, " Not only does it appear to be effective, but

it's very selective. " He continued " it's highly toxic to the cancer

cells,

but has a marginal impact on normal breast cells. "

 

Dr. Lai has been investigating the potential of Artemisinin in regard

to treating various types of cancer for over seven years with

consistently promising results. He has developed a " cocktail "

consisting of

holotransferrin, a substance that binds with a cancer

cells " transferring

receptors, " the part of the cell that absorbs iron and a water

soluble

form of Artemisinin. Cancer cells normally absorb much more iron than

healthy cells. Therefore the chemical cocktail is attracted to the

diseased cells and brings the Artemisinin along with it.

 

Although full-scale human trials have not been conducted as yet, in

one

animal trial, a dog with severe bone cancer was completely cured

within

five days of being given the Artemisinin cocktail.

 

According to Dr. Lai, Artemisinin could open the door to a whole new

era of cancer treatment. Patients could be given a prescription for a

pill they could take at home without the need to go through expensive

hospital-based treatments.

 

" That would be very easy, and this [Artemisinin] could make that

possible. The cost is another plus - at $2 a dose, it's very cheap.

And with

millions of people who have already taken Artemisinin for Malaria we

have a track record showing that it's safe. "

 

Dr. Lai continued " The fascinating thing is that this was something

the

Chinese used thousands of years ago. We simply found a different

application. "

 

The real question is not whether Artemisinin will eventually become

part of the arsenal for fighting cancer as it has become part of the

arsenal for fighting Malaria. Given the amazing results of Dr. Lai's

research, it undoubtedly will. The real question is whether Big

Pharma and its

allies in government will make the public wait three decades before

it

becomes available.

[Guest guest]

Hello Ykcul: Thank you for submitting this article. I have been using Artemesia

Absynthia in combination with other anti-parasitic herbs on cancer patients with

great success. It was deemed a crazy idea at the time by the group here, but as

you have found- not so crazy at all. It will also change a person's HIV status

from positive to negative. This is BIG news that it will be used for Malaria,

but the bigger news is yet to come. Please keep me posted as I have a direct

interest in proving this. Bill

-

ykcul_ritsym

Chinese Medicine

Thursday, June 03, 2004 10:41 PM

Qing Hao and malaria, cancer studies

 

 

 

 

http://www.cancer-coverup.com/newsletter/06-2004/default.asp?

linkref=nl_0604

 

AN HERBAL MIRACLE DRUG?

TRADITIONAL CHINESE HERB OFFERS CURE FOR MALARIA AND POSSIBLY CANCER

 

 

BY KATHLEEN B. DEOUL

 

What if there was a disease that killed between 1.5 and 2.7 million

people a year, including at least one million children that could be

easily treated with a simple herbal extract that had negligible side

affects? What if had been known for decades that this cheap, well-

tolerated

cure was available, but its use was blocked by institutions such as

the

World Health Organization and UNICEF - the very ones charged with

improving global health? What if this disease were beginning to

spread from

the underdeveloped world to Europe and the United States?

 

Would someone be held accountable for the needless deaths and growing

threat?

 

Apparently not, because that is exactly what has happened with

Malaria

- but that's only half of the story.

 

THE SCOURGE OF MALARIA

 

Malaria is one of the triumvirate of diseases that has devastated the

developing world. Along with AIDS and Tuberculosis, it has reached

pandemic proportions in Asia and Africa with some 120 million

clinical cases

reported annually. Although the vast majority of Malaria deaths occur

in Africa, at lease 40% of the World's population has been exposed to

the parasite. Indeed, it is estimated that 300 million people carry

the

parasite. This compares with around 40 million AIDS carriers and is

exceeded only by Tuberculosis which may be carried by as much as one-

third

of the world's population.

 

What is particularly disturbing about Malaria, however, is that over

the last century every time a new drug has been developed to combat

it,

the parasite has adapted and developed a resistance. In the 1950s

quinine-based drugs such as Chloraquine and Primaquine proved highly

effective in combating Malaria, but today, anywhere from 50% to 90%

of new

cases are proving resistant.

 

Over the past fifteen years, the older quinine-based drugs were

replaced as the treatment of choice by Lariam (Mefloquine), a drug

developed

by the United States Army for soldiers serving in Vietnam. Lariam was

first produced at the Walter Reed Army Institute of Research in 1963.

Licensed to Swiss pharmaceutical giant Hoffman LaRoche, it was

approved

for general use in May of 1989. Each year, thousands of civilians

traveling abroad as well as U.S. military and Peace Corps personnel

take

Lariam to protect them against Malaria.

 

PROBLEMS WITH LARIAM

 

However, like their predecessors, drugs such as Lariam are now also

losing their effectiveness. Moreover, serious side effects have been

associated with Lariam, including extreme neuropsychiatric disorders.

These

disorders are suspected of sparking a series of murders at Ft. Bragg,

N.C. by soldiers returning from Afghanistan where they were

administered

the drug.

 

Concern over the possible neuropsychiatric side effects of Lariam

caused the FDA to require a change to the product's label in 2002

that reads

in part:

 

" Mefloquine may cause psychiatric symptoms in a number of patients

ranging from anxiety, paranoia and depression to hallucinations and

psychotic behavior. On occasions these symptoms have been reported to

continue

long after mefloquine has been stopped. Rare cases of suicidal

ideation

and suicide have been reported though no relationship to drug

administration has been confirmed. "

 

What makes the concern over growing drug resistance to Malaria an

even

more urgent problem is that the increase in global travel, especially

to areas such as Africa and Southeast and Southwest Asia where

Malaria

is common raise the specter of its return to the United States. Other

tropical diseases such as the West Nile Virus have already made there

way

here, and some fear it is only a matter of time before Malaria does

so

as well.

 

But is there a solution?

 

AN HERBAL SOLUTION?

 

Surprisingly, one has been available for at least three decades, but

it

has been resisted by both Big Pharma and the international

institutions

that do its bidding.

 

At about the same time the U.S. Army was looking for a new Malaria

drug

to give to soldiers fighting in Vietnam, the Chinese military was

engaged in the same task to protect their own troops and those of

North

Vietnam. Their approach, however, was quite different.

 

China has a tradition of using herbal medicine that dates back over

2,000 years. In 1965, Chinese military researchers began looking at

traditional herbal remedies to see if they could find one that was

effective

against the strain of Malaria endemic to Vietnam. In short order they

hit on an herb known as " sweet wormwood. "

 

Sweet wormwood had been used to treat a variety of illnesses in China

for more than two millennia. Normally administered as a tea, it had

no

noticeable side effects and seemed quite effective. The Chinese

military

researchers were able to isolate the active ingredient in sweet

wormwood, a substance called Artemisinin, and to develop a simple

process to

extract it.

 

The results were astounding.

 

ARTEMISININ'S EFFECTIVENESS

 

They found that Artemisinin was effective against all strains of

Malaria, and more important, its therapeutic action was stunningly

rapid. In

one clinical trial, it was found to destroy 95% of the Malaria

parasites in patients within twenty hours. The fever typically

accompanying a

Malaria infection was gone within eight hours. Moreover, there were

no

side effects. Other studies of Artemisinin confirmed its

effectiveness

and rapid action - something particularly important for the treatment

of

very young children who account for 90% of all Malaria deaths.

 

But that wasn't all of the good news concerning Artemisinin.

 

Because sweet wormwood is easy to cultivate and because the

extraction

process to separate out the Artemisinin is simple, it was cheap to

manufacture. In other words, it was the perfect answer to the

developing

world's Malaria pandemic.

 

Of course, this new " miracle " cure was embraced by the World Health

Organization, UNICEF and the other international organizations trying

to

combat global public health problems - at least that's what you would

think. Unfortunately you would be wrong.

 

Their reaction was exactly the opposite.

 

ESTABLISHMENT RESISTANCE AND REVERSAL

 

In 2002, Dr. Dennis Carroll, a health advisor to the Agency for

International Development called Artemisinin " . not ready for prime

time . "

 

The World Bank and UNICEF objected to the herbal remedy claiming it

was

" too expensive. " At the time, a dose of Artemisinin sold for around

$2

whereas a single dose of Lariam costs from $4.50 to $6.00!

 

Suddenly, last April, Dr. Carroll reversed himself and became a

cheerleader for Artemisinin.

 

How could this happen?

 

Well, he was not exactly a cheerleader for Artemisinin. Rather, he

became a cheerleader for what is termed " ACT " or " Artemisinin

Combination

Therapy. " Under this approach Artemisinin is combined with a

pharmaceutical product - usually a drug called Lumefantrine that is

produced by

Novartis, the huge Swiss drug conglomerate. Interestingly, in poor

countries Novartis sells the combination under the brand

name " Coartem " for

about 90 cents a dose. In the Developed World, however, it sells the

same drug under the brand name Riamet for around $20 a dose.

 

While Novartis could not patent Artemisinin, because as a plant, it

was

a naturally occurring substance, it can patent the combination -

ensuring its coffers will be fattened!

 

But that's not all!

 

Even though the World Health Organization now says it needs at least

100 million doses of the combination drug by next year, Novartis

managed

to get it qualified as an " orphan drug " under FDA regulations making

it

eligible for preferential tax and investment treatment!

 

So now that Big Phama can make a profit, the ancient Chinese herb has

suddenly become the " next new thing " in the pharmaceutical industry.

 

The question is how many children died needlessly while greedy

executives in corporate board rooms were protecting their profits?

 

If you only take the period from 1989 when Lariam, the last " next new

thing " for Malaria came onto the market into account, the death toll

comes to around 15 million!

 

But at least Artemisinin is now becoming available, and not a moment

too soon, because conventional pharmaceutical remedies are rapidly

losing

their effectiveness.

 

In Uganda, for example, a country which had not previously had a

significant drug resistance problem, the number of Malaria cases not

responding to existing pharmaceutical products rose from 6% in 2000

to 31% in

2003. Similar patterns of rapidly growing drug resistance are being

experienced elsewhere.

 

BIG PHARMA'S PLOY

 

Of course, Big Pharma uses this fact as a justification for using a

" combined drug therapy. " They claim that using Artemisinin in

combination

with Lumefantrine will protect the herb against losing its

effectiveness. This makes sense on first glance except for one thing:

Artemisinin

has been used for over 2,000 years without losing its punch.

 

Why would it suddenly do so now?

 

The simple truth is that Novartis is not afraid of Artemisinin losing

its medicinal power. It's afraid of losing the drug's financial

power.

As long as it is sold in combination with a conventional

pharmaceutical

product, the combination can be patented even if the herb cannot.

That

means that whenever the patent on Lumefantrine is set to expire, all

that Novartis has to do is combine it with another pharmaceutical

product

- it really doesn't matter what since it's the herb that's providing

the greatest medical benefit - and apply for a new patent! It

effectively

creates Big Pharma's fondest dream - a patent that will never expire!

 

Not only that, but by following the two-tiered sales approach and

having one relatively cheap brand name Novartis uses in poor

countries and

another expensive one for the rest of the world, the company can

continue to watch its profits grow while avoiding criticism for

exploiting

poor nations.

 

As if its indefinite patent protection weren't enough, institutions

such as the World Health Organization, the Global Fund for AIDS

Tuberculosis and Malaria and the U.S. Agency for International

Development are

providing grants to farmers to grow more sweet wormwood so that

sufficient supplies of the herb are available. That these grants also

serve to

keep manufacturing costs down for Novartis thereby making their

profits

larger is yet another benefit to the pharmaceutical giant.

 

But how does Artemisinin work? The answer to this question may have

implications for global health that go far beyond its effectiveness

against Malaria.

 

Artemisinin contains a bioactive peroxide molecule. It is this

molecule

that is the key to its effectiveness against the Malaria parasite.

Malaria grows in the body's erythrocytes, or red blood cells.

Hemoglobin, a

major component of red blood cells, contains large amounts

of " unbound "

or free iron. The iron plays a crucial role in the function of red

blood cells to transport oxygen throughout the body. The peroxide

molecule

in Artemisinin reacts with the iron in the red blood cells to create

free radicals that in turn destroy the parasite's membranes, killing

it.

This mechanism may be the reason why Malaria parasites are unable to

develop a resistance to Artemisinin.

 

The belief that oxygen plays a key role in the Artemisinin anti-

malaria

mechanism has been reinforced by studies of derivatives of the

substance that do not contain the peroxide molecule. These were found

to be

ineffective against malaria. Further, when other drugs such as

miconazole

and doxorubicin that also generate free radicals through an oxygen

interaction were used in conjunction with Artemisinin, its effect was

enhanced. Conversely when substances that retard free radical

creation such

as vitamin E were used in conjunction, its effect was reduced.

 

In a separate study where the antioxidant defenses of rats were

manipulated, it was discovered that those with weaker antioxidant

defenses

were more resistant to the Malaria parasite, whereas those with

enhanced

antioxidant defenses were more vulnerable to the disease.

 

But why is it so important that Artemisinin transport oxygen to

cells?

The answer lies in the research of German Nobel Laureate Otto

Warburg.

 

A POSSIBLE CANCER CURE?

 

Warburg won the Nobel Prize in 1928 for describing the way a cancer

cell functions. A key element of his research was to establish that

cancer

cells were " anaerobic. " That is to say that they required an ABSENCE

of

oxygen to survive. Since 1928, countless researchers have worked to

find a way to transport oxygen to cancer cells. Although some

researchers,

such as Dr. Keith Brewer, developed treatments based on this

principle,

their discoveries were either ignored or attacked.

 

But in the case of Artemisinin, the fact that it is approved by the

FDA

for use in humans may finally open the door to an oxygen-based

approach

to cancer treatment. Once a drug is approved for one purpose, it can

be

prescribed by physicians to treat any disease they deem appropriate.

This practice is called " off-label prescribing " and is widespread

within

the medical community. Soon, though, it may not be necessary to

engage

in such subterfuge.

 

Professor Henry Lai and Assistant Professor Narendra Singh of the

University of Washington have been conducting in vitro experiments to

determine the effectiveness of Artemisinin in fighting cancer. A

study

concerning their research published in the Journal Life Sciences

described

how the compound killed virtually all human breast cancer cells

exposed

to it within sixteen hours.

 

According to Dr. Lai, " Not only does it appear to be effective, but

it's very selective. " He continued " it's highly toxic to the cancer

cells,

but has a marginal impact on normal breast cells. "

 

Dr. Lai has been investigating the potential of Artemisinin in regard

to treating various types of cancer for over seven years with

consistently promising results. He has developed a " cocktail "

consisting of

holotransferrin, a substance that binds with a cancer

cells " transferring

receptors, " the part of the cell that absorbs iron and a water

soluble

form of Artemisinin. Cancer cells normally absorb much more iron than

healthy cells. Therefore the chemical cocktail is attracted to the

diseased cells and brings the Artemisinin along with it.

 

Although full-scale human trials have not been conducted as yet, in

one

animal trial, a dog with severe bone cancer was completely cured

within

five days of being given the Artemisinin cocktail.

 

According to Dr. Lai, Artemisinin could open the door to a whole new

era of cancer treatment. Patients could be given a prescription for a

pill they could take at home without the need to go through expensive

hospital-based treatments.

 

" That would be very easy, and this [Artemisinin] could make that

possible. The cost is another plus - at $2 a dose, it's very cheap.

And with

millions of people who have already taken Artemisinin for Malaria we

have a track record showing that it's safe. "

 

Dr. Lai continued " The fascinating thing is that this was something

the

Chinese used thousands of years ago. We simply found a different

application. "

 

The real question is not whether Artemisinin will eventually become

part of the arsenal for fighting cancer as it has become part of the

arsenal for fighting Malaria. Given the amazing results of Dr. Lai's

research, it undoubtedly will. The real question is whether Big

Pharma and its

allies in government will make the public wait three decades before

it

becomes available.

 

 

 

 

 

 

 

 

Membership requires that you do not post any commerical, swear, religious,

spam messages,flame another member or swear.

 

http://babel.altavista.com/

 

and adjust

accordingly.

 

If you , it takes a few days for the messages to stop being

delivered.

 

 

 

[Guest guest]

Hi Bill!

 

When you do prove it, make sure you tell all of us . . .

 

At 01:25 PM 6/4/2004, you wrote:

>Hello Ykcul: Thank you for submitting this article. I have been using

>Artemesia Absynthia in combination with other anti-parasitic herbs on

>cancer patients with great success. It was deemed a crazy idea at the time

>by the group here, but as you have found- not so crazy at all. It will

>also change a person's HIV status from positive to negative. This is BIG

>news that it will be used for Malaria, but the bigger news is yet to come.

>Please keep me posted as I have a direct interest in proving this. Bill

 

>

><http://www.cancer-coverup.com/newsletter/06-2004/default.asp?linkref=nl_0604>

>

> AN HERBAL MIRACLE DRUG?

> TRADITIONAL CHINESE HERB OFFERS CURE FOR MALARIA AND POSSIBLY CANCER

 

Regards,

 

Pete